Pilot Study of ONO-1101 in Patients Scheduled for Multi-slice CT
NCT00311038 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 90
Last updated 2012-06-13
Summary
The purpose of this study is to evaluate the efficacy and safety of ONO-1101 in patients scheduled for multi-slice CT.
Conditions
Interventions
- DRUG
-
ONO-1101
Sponsors & Collaborators
-
Ono Pharmaceutical Co. Ltd
lead INDUSTRY
Principal Investigators
-
Project Leaders Development Planning · Ono Pharmaceutical Co. Ltd
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Max Age
- 74 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-04-30
Countries
- Japan
More Related Trials
-
Dose Finding Study of PB127 Ultrasound Contrast Agent in Healthy Volunteers and Patients With Coronary Artery Disease
NCT00584818 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease 007
NCT00595673 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Preliminary Efficacy Study of EE001 in Health/Patients Adults with Mild, Moderate, or Severe (NYHA II-IV) Cardiac Insufficiency
NCT06884111 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Safety and Effectiveness of Oral Anticoagulants in Patients With Non-valvular Atrial Fibrillation
NCT03570047 ·Status: COMPLETED
-
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stable Coronary Heart Disease
NCT03351738 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Trial of Ranolazine to Treat Patients With Dilated Cardiomyopathy
NCT02133911 ·Status: COMPLETED ·Phase: PHASE2
-
ESSENTIAL-"The Studies of Oral Enoximone Therapy in Advanced Heart Failure"
NCT00051285 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of Mavacamten in Obstructive Hypertrophic Cardiomyopathy
NCT05414175 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 in Subjects With Obstructive Hypertrophic Cardiomyopathy
NCT04418297 ·Status: TERMINATED ·Phase: PHASE1
-
Pilot Study of COR-1 in Heart Failure
NCT01391507 ·Status: COMPLETED ·Phase: PHASE2
-
Ranolazine in Ischemic Cardiomyopathy
NCT01345188 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Learn More About How Well Aficamten Works in Japanese Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy
NCT07023341 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Safety, Pharmacokinetic and Pharmacodynamic Study of COR-1, an Anti-ß1 Receptor Antibody Cyclopeptide
NCT01043146 ·Status: COMPLETED ·Phase: PHASE1
-
Dose Ranging Study of Dronedarone for the Control of Ventricular Rate in Japanese Patients With Permanent Atrial Fibrillation
NCT01213368 ·Status: COMPLETED ·Phase: PHASE2
-
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
NCT01151137 ·Status: TERMINATED ·Phase: PHASE3
-
Prospective Study of End Stage Renal Disease Patients With Coronary Artery Disease Treated by Oral Nicorandil
NCT01475123 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Pirfenidone Treat Myocardial Fibrosis After Acute Myocardial Infarction
NCT05531955 ·Status: UNKNOWN ·Phase: PHASE2
-
A Trial to Evaluate the Effect of Delgocitinib on the Heart Rhythm of Healthy People
NCT05050279 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Special Drug Use Surveillance for Entresto Tablets
NCT04781881 ·Status: COMPLETED
-
Concentrations of Amiodarone in Fat Tissue During Chronic Treatment
NCT00313443 ·Status: COMPLETED ·Phase: PHASE4
-
Study of [3H] BMS747158 in Healthy Male Subjects
NCT00930631 ·Status: COMPLETED ·Phase: PHASE1
-
Danhong Injection in the Treatment of Unstable Angina Pectoris
NCT02007187 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Assessing the Effect of RO4607381 on Vascular Function in Patients With Coronary Heart Disease (CHD) or CHD-Risk Equivalent Patients
NCT00655538 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 1 Trial to Determine Dosimetry, Biodistribution and Safety of LMI 1195-101 in Healthy Subjects and Patients With Heart Failure
NCT00891241 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease
NCT00595244 ·Status: COMPLETED ·Phase: PHASE3